This document discusses HIV/AIDS symptoms, transmission, and treatment. It notes that many people are unaware they have HIV as symptoms may not appear for years. When symptoms do occur, they are often flu-like. HIV is mainly transmitted through unprotected sex and sharing needles but can also be passed from mother to child. Treatment involves combinations of antiretroviral drugs to suppress the virus and boost immunity, though medications do not cure HIV.
This document discusses HIV/AIDS symptoms, transmission, and treatment. It notes that many people are unaware they have HIV as symptoms may not appear for years. When symptoms do occur, they are often flu-like. HIV is mainly transmitted through unprotected sex and sharing needles but can also be passed from mother to child. Treatment involves combinations of antiretroviral drugs to suppress the virus and boost immunity, though medications do not cure HIV.
This document discusses HIV/AIDS symptoms, transmission, and treatment. It notes that many people are unaware they have HIV as symptoms may not appear for years. When symptoms do occur, they are often flu-like. HIV is mainly transmitted through unprotected sex and sharing needles but can also be passed from mother to child. Treatment involves combinations of antiretroviral drugs to suppress the virus and boost immunity, though medications do not cure HIV.
This document discusses HIV/AIDS symptoms, transmission, and treatment. It notes that many people are unaware they have HIV as symptoms may not appear for years. When symptoms do occur, they are often flu-like. HIV is mainly transmitted through unprotected sex and sharing needles but can also be passed from mother to child. Treatment involves combinations of antiretroviral drugs to suppress the virus and boost immunity, though medications do not cure HIV.
Download as DOCX, PDF, TXT or read online from Scribd
Download as docx, pdf, or txt
You are on page 1of 3
1
HIV/AIDS Symptoms and Signs
Many people with HIV do not know they are infected. In the United States, it is likely that 20% of HIV-positive individuals are unaware of their infection. HIV infection progresses in different stages. Many people do not develop symptoms after they first are infected with HIV. Others will have signs and symptoms in the early stage of HIV infection, referred to as primary or acute HIV infection. The most common symptoms are similar to a flu-like illness within several days to weeks after exposure to the virus. Early HIV symptoms include fever, headache, tiredness, rash, sore throat, and enlarged lymph nodes in the neck. A characteristic feature of primary HIV infection is open sores or ulcers in the mouth. These symptoms usually disappear within a few weeks. After that, the person feels normal and has no symptoms. This asymptomatic phase often lasts for years. The progression of disease varies widely among individuals. This stage of HIV infection may last from a few months to more than 10 years. During this period, the virus continues to multiply actively and infects and kills the cells of the immune system. The virus destroys the cells that are the primary infection fighters, a type of white blood cell called CD4 cells. Even though the person has no symptoms, he or she is contagious and can pass HIV to others through the routes listed above.
HIV/AIDS Transmission HIV is transmitted when the virus enters the body, usually by injecting infected cells or semen. The virus can enter in several possible ways. Most commonly, HIV infection is spread by having sex with an infected partner. The virus can enter the body through the lining of the vagina, vulva, penis, rectum, or mouth during sex. Although intercourse is the primary risk factor, oral sex transmission is also possible. HIV frequently spreads among injection-drug users who share needles or syringes that are contaminated with blood from an infected person. Women can transmit HIV to their babies during pregnancy or birth, when infected maternal cells enter the baby's circulation, or through breastfeeding. HIV can be spread in health-care settings through accidental needle sticks or contact with contaminated fluids. 2 Very rarely, HIV spreads through transfusion of contaminated blood or blood components. All blood products are tested to minimize this risk. If tissues or organs from an infected person are transplanted, the recipient may acquire HIV. Donors are now tested for HIV to minimize this risk. HIV has been spread when organs from an infected person are transplanted into an uninfected recipient. Because donors are tested for HIV routinely in the United States, this does not usually happen. However, a recent incident in Taiwan occurred when the HIV test results for the donor were mistakenly thought to have been negative. People who already have a sexually transmitted infections, such as syphilis, genital herpes, chlamydia, human papillomavirus (HPV), gonorrhea, or bacterial vaginosis, are more likely to acquire HIV infection during sex with an infected partner. The virus does not spread through casual contact such as preparing food, sharing towels and bedding, or via swimming pools, telephones, or toilet seats. The virus is also unlikely to be spread by contact with saliva, unless it is contaminated with blood.
HIV/AIDS Treatment andMedications Over the past years, several drugs have become available to fight both the HIV infection and its associated infections and cancers. These drugs are called highly active antiretroviral therapy (HAART) and have substantially reduced HIV-related complications and deaths. However, medications do not cure HIV/AIDS. In one case, a patient treated for cancer apparently was cured of HIV through use of a stem cell transplant, but this "stem cell cure" is not recommended for HIV due to the high risk of mortality and uncertain chance of success. Another case involved a baby in Mississippi who was treated aggressively 30 hours after birth with antiretroviral drugs and is now off HIV drugs and considered "functionally cured." This is, however, an isolated event. Therapy is initiated and individualized under the supervision of a physician who is an expert in the care of HIV-infected patients. A combination of at least three drugs is recommended to suppress the virus from replicating and boost the immune system. The following are the different classes of medications used in treatment. Reverse transcriptase inhibitors: These drugs inhibit the ability of the virus to make copies of itself. The following are examples: Nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs): These include medications such as zidovudine (AZT/Retrovir), didanosine (ddI/Videx), stavudine (d4T/Zerit), lamivudine (3TC/Epivir), abacavir (ABC/Ziagen), emtricitabine (FTC/Emtriva), and tenofovir (TDF/Viread). Combination NRTIs include Truvada (tenofovir/emtricitabine), Combivir (zidovudine/lamivudine), Epzicom (abacavir/lamivudine), and Trizivir (abacavir/zidovudine/lamivudine). 3 Non-nucleoside reverse transcriptase inhibitors (NNRTIS) are commonly used in combination with NRTIs to help keep the virus from multiplying. Examples of NNRTIs are efavirenz (Sustiva), nevirapine (Viramune), delavirdine (Rescriptor), and etravirine (Intelence). Rilpivirine (Edurant), the newest member of this class of drugs, was approved by the U.S. FDA in May of 2011. Two complete HIV treatment regimens that combine two NRTIs and one NNRTI in one pill taken once a day are available for convenience. Atripla: a combination of efavirenz, emtricitabine, and tenofovir. Atripla was approved for use by the FDA in 2006. Complera: a combination of rilpivirine, emtricitabine, and tenofovir. This combination pill was approved in August 2011 by the FDA as another first-line treatment for HIV infection in patients who need to start therapy. Protease inhibitors (PIs): These medications interrupt virus replication at a later step in its life cycle, preventing cells from producing new viruses. These include ritonavir (Norvir), a lopinavir and ritonavir combination (Kaletra), saquinavir (Invirase), indinavirsulphate (Crixivan), fosamprenavir (Lexiva), darunavir (Prezista), atazanavir (Reyataz), tipranavir (Aptivus), and nelfinavir (Viracept). Using PIs with NRTIs reduces the chances that the virus will become resistant to medications. Fusion and entry inhibitors are newer agents that keep HIV from entering human cells. Enfuvirtide (Fuzeon/T20) was the first drug in this group. It is given in injectable form like insulin. Another drug called maraviroc (Selzentry) binds to a protein on the surface of the human cell and can be given by mouth. Both drugs are used in combination with other anti-HIV drugs. Integrase inhibitors stop HIV genes from becoming incorporated into the human cell's DNA. This is a newer class of drugs recently approved to help treat those who have developed resistance to the other medications or used in initial treatment in combination with NRTIs. Raltegravir (Isentress) was the first drug in this class approved by the FDA in 2007. Elvitegravir is the latest integrase inhibitor developed and FDA-approved in 2012 as a component of a fixed-dose combination pill taken once daily called Stribild (elvitegravir/cobicistat/tenofovir/emtricitabine). Pregnant women who are HIV-positive should seek care immediately because HAART therapy reduces the risk of transmitting the virus to the fetus. Therapy can also be given during childbirth, or perinatal period, in order to help prevent HIV infection in the newborn. There are certain drugs, however, that are harmful to the baby. Therefore, seeing a physician to discuss anti-HIV medications is crucial.